These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 24611770)
1. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis. Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770 [TBL] [Abstract][Full Text] [Related]
2. Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen. Chang KC; Liang JT; Tsai PS; Wu MS; Hsu KL Br J Pharmacol; 2009 Aug; 157(8):1419-26. PubMed ID: 19681870 [TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of glycation and AGE formation. Rahbar S Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884 [TBL] [Abstract][Full Text] [Related]
4. Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes. Chang KC; Tseng CD; Chou TF; Cho YL; Chi TC; Su MJ; Tseng YZ Eur J Clin Invest; 2006 Jan; 36(1):1-7. PubMed ID: 16403003 [TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes. Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374 [TBL] [Abstract][Full Text] [Related]
6. Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats. Chang KC; Hsu KL; Tseng CD; Lin YD; Cho YL; Tseng YZ Br J Pharmacol; 2006 Apr; 147(8):944-50. PubMed ID: 16491102 [TBL] [Abstract][Full Text] [Related]
7. Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation. Wu ET; Liang JT; Wu MS; Chang KC Exp Gerontol; 2011 Jun; 46(6):482-8. PubMed ID: 21316441 [TBL] [Abstract][Full Text] [Related]
8. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Figarola JL; Scott S; Loera S; Tessler C; Chu P; Weiss L; Hardy J; Rahbar S Diabetologia; 2003 Aug; 46(8):1140-52. PubMed ID: 12845431 [TBL] [Abstract][Full Text] [Related]
9. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats. Babu PV; Sabitha KE; Srinivasan P; Shyamaladevi CS Pharmacol Res; 2007 May; 55(5):433-40. PubMed ID: 17336542 [TBL] [Abstract][Full Text] [Related]
11. Prevention of arterial stiffening by using low-dose atorvastatin in diabetes is associated with decreased malondialdehyde. Wang CH; Chang RW; Ko YH; Tsai PR; Wang SS; Chen YS; Ko WJ; Chang CY; Young TH; Chang KC PLoS One; 2014; 9(3):e90471. PubMed ID: 24595201 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312 [TBL] [Abstract][Full Text] [Related]
14. Effects of diabetes and gender on mechanical properties of the arterial system in rats: aortic impedance analysis. Chang KC; Hsu KL; Tseng YZ Exp Biol Med (Maywood); 2003 Jan; 228(1):70-8. PubMed ID: 12524476 [TBL] [Abstract][Full Text] [Related]
15. Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study. van Eupen MG; Schram MT; van Sloten TT; Scheijen J; Sep SJ; van der Kallen CJ; Dagnelie PC; Koster A; Schaper N; Henry RM; Kroon AA; Smit AJ; Stehouwer CD; Schalkwijk CG Hypertension; 2016 Oct; 68(4):956-63. PubMed ID: 27550921 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic rats. Cheng G; Wang LL; Long L; Liu HY; Cui H; Qu WS; Li S Br J Pharmacol; 2007 Dec; 152(8):1196-206. PubMed ID: 17965740 [TBL] [Abstract][Full Text] [Related]
18. Effects of olmesartan on arterial stiffness in rats with chronic renal failure. Chuang YC; Wu MS; Su YK; Fang KM Cardiovasc Diabetol; 2012 Jun; 11():66. PubMed ID: 22694778 [TBL] [Abstract][Full Text] [Related]
19. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling. Jing YH; Chen KH; Yang SH; Kuo PC; Chen JK Diabetes Metab Res Rev; 2010 Mar; 26(3):212-22. PubMed ID: 20474069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]